1-3 of 3
Koji Nagafuji
Close
Sort by
Journal Articles

Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study

Clinical Trials & Observations
Kinuko Mitani, Jong Wook Lee, Jun Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, Koji Nagafuji, Kensuke Usuki, Nobuhiko Uoshima, Tomoaki Fujisaki, Hiroshi Kosugi, Itaru Matsumura, Ko Sasaki, Masahiro Kizaki, Masashi Sawa, Michihiro Hidaka, Naoki Kobayashi, Satoshi Ichikawa, Yuji Yonemura, Kenta Murotani, Mami Shimizu, Akira Matsuda, Keiya Ozawa, Shinji Nakao
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1415–1419.
https://doi.org/10.1182/bloodadvances.2023010959
Published: 2024
Includes: Supplemental data
Journal Articles

Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study

Clinical Trials & Observations
Ayumu Ito, Nobuaki Nakano, Takashi Tanaka, Shigeo Fuji, Junya Makiyama, Yoshitaka Inoue, Ilseung Choi, Hirohisa Nakamae, Koji Nagafuji, Ken Takase, Shinichiro Machida, Tsutomu Takahashi, Yasushi Sawayama, Tomohiko Kamimura, Koji Kato, Toshiro Kawakita, Masao Ogata, Rika Sakai, Souichi Shiratori, Kaoru Uchimaru, Yoshihiro Inamoto, Atae Utsunomiya, Takahiro Fukuda
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4156–4166.
https://doi.org/10.1182/bloodadvances.2021004932
Published: 2021
Includes: Supplemental data
Journal Articles

Primary human herpesvirus 8–negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis

Daisuke Kaji, Yasunori Ota, Yasuharu Sato, Koji Nagafuji, Yasunori Ueda, Masataka Okamoto, Yasushi Terasaki, Naoko Tsuyama, Kosei Matsue, Tomohiro Kinoshita, Go Yamamoto, Shuichi Taniguchi, Shigeru Chiba, Koichi Ohshima, Koji Izutsu
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4442–4450.
https://doi.org/10.1182/bloodadvances.2020002293
Published: 2020
Includes: Supplemental data